PHCFM African Journal of Primary Health Care & Family Medicine 2071-2928 2071-2936 AOSIS PHCFM-17-5273 10.4102/phcfm.v17i1.5273 Correction Corrigendum: Utilisation of antibiotics in a community pharmacy: A case from North-West, South Africa https://orcid.org/0000-0002-8834-7345 Nsingo Zanele 1 https://orcid.org/0000-0002-9613-1501 Bangalee Varsha 1 https://orcid.org/0000-0001-6431-2140 Johnston Deanne 1 School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa Corresponding author: Zanele Nsingo, nsingozanele1234@gmail.com 19112025 2025 17 1 5273 © 2025. The Authors 2025 Licensee: AOSIS. This work is licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

In the published article, Nsingo Z, Bangalee V, Johnston D. Utilisation of antibiotics in a community pharmacy: A case from North-West, South Africa. Afr J Prm Health Care Fam Med. 2025;17(1), a4943. https://doi.org/10.4102/phcfm.v17i1.4943, on page 5, under the heading ‘Choice of antibiotic and payment method’, the following was incorrectly formulated.

Instead of:

Both generic and originator brands for fosfomycin (originator, n = 102; generic, n = 157) and nitrofurantoin (originator, n = 62; generic, n = 62) were dispensed.

It should be:

Both generic and originator brands for fosfomycin (originator, n = 102; generic, n = 157) and nitrofurantoin (originator, n = 62; generic, n = 62) were dispensed. Correct formula is (originator, n = 102; generic, n = 157) and nitrofurantoin (originator, n = 82; generic, n = 24).

On page 6, paragraph 4, there was a spelling mistake. Instead of: Etitrea, the correct spelling is: Eritrea.

On page 3, Table 1, Nitrofurantoin was listed twice and Levofloxacin was misspelt.

Instead of:

Overview of antibiotics dispensed according to age and gender in percentages (%).

Antibiotic Age group (years)
 Gender
< 2 (n = 165) 2–11 (n = 889) 12–17 (n = 294) 18–64 (n = 8446) ≥ 65 (n = 674) Male (n = 5596) Female (n = 4870)
Azithromycin (n = 1849) (Watch) 1.6 8.8 2.7 82.0 5.1 54.2 45.9
Clavulanic acid and amoxicillin (n = 1814) (Access) 1.6 12.0 3.8 76.8 5.9 59.2 40.8
Amoxcillin (n = 1490) (Access) 2.4 10.0 3.2 80.6 3.9 45.1 54.9
Metronidazole (n = 1182) (Access) 0.3 4.2 1.9 89.3 4.4 46.3 53.7
Cefuroxime (n = 866) (Watch) 2.5 14.7 5.2 71.9 5.7 63.1 37.0
Ciprofloxacin (n = 641) (Watch) 0.3 1.1 1.0 83.3 14.4 52.9 47.1
Cefpodoxime (n = 537) (Watch) 5.8 18.8 2.6 66.7 6.2 57.7 42.3
Co-trimoxazole (n = 508) (Access) 1.6 6.7 0.6 84.4 6.7 42.5 57.5
Doxycycline (n = 315) (Access) 0.0 0.3 1.6 93.0 5.1 51.8 48.3
Fosfomycin (n = 259) (Access) 0.0 0.4 3.1 84.2 12.4 60.2 39.8
Clarithromycin (n = 257) (Watch) 0.0 0.4 1.2 85.6 12.9 56.4 43.9
Kanamycin (n = 199) (Watch) 2.5 15.6 5.0 71.9 5.0 62.8 37.2
Flucloxacillin and amoxicillin (n = 107) (Watch) 0.1 2.8 3.7 87.9 4.7 51.4 48.6
Clindamycin (n = 102) (Access) 0.0 0.0 2.0 81.4 16.7 57.9 42.2
Nitrofurantoin (n = 76) (Access) 0.0 0.0 1.3 75.0 23.7 60.5 39.5
Dapsone (n = 48) (Access) 0.0 0.0 0.0 100.0 0.0 58.3 41.7
Ampicillin and cloxacillin (n = 34) (Access) 0.0 0.0 0.0 85.3 14.7 38.2 61.8
Lymecycline (n = 33) (Access) 0.0 0.0 3.0 84.9 12.1 78.8 21.2
Cefixime (n = 31) (Watch) 0.0 3.2 0.0 96.7 0.0 38.7 61.3
Nitrofurantoin (n = 30) (Access) 0.0 10.0 0.0 76.7 13.3 53.3 46.7
Erythromycin (n = 28) (Watch) 0.0 3.6 7.1 78.6 10.7 60.7 39.3
Moxifloxacin (n = 24) (Watch) 0.0 0.0 0.0 79.2 20.8 75.0 25.0
Flucloxacillin (n = 19) (Access) 0.0 10.5 10.5 73.7 5.3 36.8 63.2
Levonoxacillin (n = 19) (Watch) 0.0 0.0 0.0 89.5 10.5 31.6 68.4

It should be:

Overview of antibiotics dispensed according to age and gender in percentages (%).

Antibiotic Age group (years)
 Gender
< 2 (n = 165) 2–11 (n = 889) 12–17 (n = 294) 18–64 (n = 8 446) ≥ 65 (n = 674) Male (n = 5 596) Female (n = 4 870)
Azithromycin (n = 1849) (Watch) 1.6 8.8 2.7 82.0 5.1 54.2 45.9
Clavulanic acid and amoxicillin (n = 1 814) (Access) 1.6 12.0 3.8 76.8 5.9 59.2 40.8
Amoxicillin (n = 1 490) (Access) 2.4 10.0 3.2 80.6 3.9 45.1 54.9
Metronidazole (n = 1 182) (Access) 0.3 4.2 1.9 89.3 4.4 46.3 53.7
Cefuroxime (n = 866) (Watch) 2.5 14.7 5.2 71.9 5.7 63.1 37.0
Ciprofloxacin (n = 641) (Watch) 0.3 1.1 1.0 83.3 14.4 52.9 47.1
Cefpodoxime (n = 537) (Watch) 5.8 18.8 2.6 66.7 6.2 57.7 42.3
Co-trimoxazole (n = 508) (Access) 1.6 6.7 0.6 84.4 6.7 42.5 57.5
Doxycycline (n = 315) (Access) 0.0 0.3 1.6 93.0 5.1 51.8 48.3
Fosfomycin (n = 259) (Access) 0.0 0.4 3.1 84.2 12.4 60.2 39.8
Clarithromycin (n = 257) (Watch) 0.0 0.4 1.2 85.6 12.9 56.4 43.9
Kanamycin (n = 199) (Watch) 2.5 15.6 5.0 71.9 5.0 62.8 37.2
Flucloxacillin and amoxicillin (n = 107) (Watch) 0.1 2.8 3.7 87.9 4.7 51.4 48.6
Clindamycin (n = 102) (Access) 0.0 0.0 2.0 81.4 16.7 57.9 42.2
Nitrofurantoin (n = 106) (Access) 0.0 2.8 0.9 75.5 20.8 58.5 41.5
Dapsone (n = 48) (Access) 0.0 0.0 0.0 100.0 0.0 58.3 41.7
Ampicillin and cloxacillin (n = 34) (Access) 0.0 0.0 0.0 85.3 14.7 38.2 61.8
Lymecycline (n = 33) (Access) 0.0 0.0 3.0 84.9 12.1 78.8 21.2
Cefixime (n = 31) (Watch) 0.0 3.2 0.0 96.7 0.0 38.7 61.3
Erythromycin (n = 28) (Watch) 0.0 3.6 7.1 78.6 10.7 60.7 39.3
Moxifloxacin (n = 24) (Watch) 0.0 0.0 0.0 79.2 20.8 75.0 25.0
Flucloxacillin (n = 19) (Access) 0.0 10.5 10.5 73.7 5.3 36.8 63.2
Levofloxacin (n = 19) (Watch) 0.0 0.0 0.0 89.5 10.5 31.6 68.4

The author(s) apologise(s) for this error. The correction does not change the study’s findings of significance or overall interpretation of the study’s results or the scientific conclusions of the article in any way.

How to cite this correction: Nsingo Z, Bangalee V, Johnston D. Corrigendum: Utilisation of antibiotics in a community pharmacy: A case from North-West, South Africa. Afr J Prm Health Care Fam Med. 2025;17(1), a5273. https://doi.org/10.4102/phcfm.v17i1.5273

Note: DOI of original article published https://doi.org/10.4102/phcfm.v17i1.4943